Seelos Therapeutics, Inc. (SEEL):企業の財務・戦略的SWOT分析

◆英語タイトル:Seelos Therapeutics, Inc. (SEEL) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY0317
◆発行会社(調査会社):GlobalData
◆発行日:2019年12月
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Seelos Therapeutics, Inc. (SEEL) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Seelos Therapeutics Inc (Seelos) is a clinical-stage biopharmaceutical company that focuses on developing novel technologies and therapeutics for the treatment of respiratory, central nervous system (CNS) and other disorders. Its lead programs include SLS-002, SLS-005, SL-007and SLS-008. Seelos pipeline products find application in treating various multiple CNS disorders including parkinson’s disease, sanflippo syndrome, suicidality post-traumatic stress disorders, major depressive disorders and other diseases such as atopic dermatitis, asthma and pediatric esophagitis. It operates along with its subsidiaries. Seelos is headquartered in New York, the US.

Seelos Therapeutics, Inc. Key Recent Developments

Nov 08,2019: Seelos Therapeutics reports Q3 2019 pipeline update
Aug 01,2019: Seelos Therapeutics reports Q2 2019 pipeline update
Jun 06,2019: Seelos Therapeutics announces appointment of Warren W. Wasiewski as Chief Scientific Officer
May 21,2019: Seelos Therapeutics reports Q1 2019 pipeline update
Mar 28,2019: Seelos Therapeutics provides update on pipeline developments and corporate highlights

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Seelos Therapeutics, Inc. – Key Facts
Seelos Therapeutics, Inc. – Key Employees
Seelos Therapeutics, Inc. – Key Employee Biographies
Seelos Therapeutics, Inc. – Major Products and Services
Seelos Therapeutics, Inc. – History
Seelos Therapeutics, Inc. – Company Statement
Seelos Therapeutics, Inc. – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Seelos Therapeutics, Inc. – Business Description
Seelos Therapeutics, Inc. – SWOT Analysis
SWOT Analysis – Overview
Seelos Therapeutics, Inc. – Strengths
Seelos Therapeutics, Inc. – Weaknesses
Seelos Therapeutics, Inc. – Opportunities
Seelos Therapeutics, Inc. – Threats
Seelos Therapeutics, Inc. – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Seelos Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Seelos Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Seelos Therapeutics, Inc., Recent Deals Summary
Section 5 – Company’s Recent Developments
Nov 08, 2019: Seelos Therapeutics reports Q3 2019 pipeline update
Aug 01, 2019: Seelos Therapeutics reports Q2 2019 pipeline update
Jun 06, 2019: Seelos Therapeutics announces appointment of Warren W. Wasiewski as Chief Scientific Officer
May 21, 2019: Seelos Therapeutics reports Q1 2019 pipeline update
Mar 28, 2019: Seelos Therapeutics provides update on pipeline developments and corporate highlights
Oct 31, 2018: Apricus Biosciences provides corporate update and third quarter 2018 financial results
Aug 09, 2018: Apricus Biosciences provides corporate update and second quarter 2018 financial results
May 03, 2018: Apricus Biosciences Provides Corporate Update and First Quarter 2018 Financial Results
Mar 01, 2018: Apricus Biosciences Provides Corporate Update, Fourth Quarter and Full Year 2017 Financial Results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Seelos Therapeutics, Inc., Key Facts
Seelos Therapeutics, Inc., Key Employees
Seelos Therapeutics, Inc., Key Employee Biographies
Seelos Therapeutics, Inc., Major Products and Services
Seelos Therapeutics, Inc., History
Seelos Therapeutics, Inc., Subsidiaries
Seelos Therapeutics, Inc., Key Competitors
Seelos Therapeutics, Inc., Ratios based on current share price
Seelos Therapeutics, Inc., Annual Ratios
Seelos Therapeutics, Inc., Annual Ratios (Cont...1)
Seelos Therapeutics, Inc., Interim Ratios
Seelos Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Seelos Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Seelos Therapeutics, Inc., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Seelos Therapeutics, Inc., Performance Chart (2014 - 2018)
Seelos Therapeutics, Inc., Ratio Charts
Seelos Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Seelos Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Seelos Therapeutics, Inc. (SEEL):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Harting AG & Co KG:企業の戦略的SWOT分析
    Harting AG & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Culver Franchising System Inc:企業の戦略・SWOT・財務情報
    Culver Franchising System Inc - Strategy, SWOT and Corporate Finance Report Summary Culver Franchising System Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • PT. SOHO Industri Pharmasi:製薬・医療:M&Aディール及び事業提携情報
    Summary PT. SOHO Industri Pharmasi (PT SOHO), a subsidiary of SOHO Global Health, is a pharmaceutical company that offers ethical, consumer health, herbal medicine and natural products. The company’s products include analgesic, anti-inflammatory, antipyretic, antibiotics, antifungal, antihistamine a …
  • CryoPort Inc (CYRX):製薬・医療:M&Aディール及び事業提携情報
    Summary Cryoport, Inc. (Cryoport) is a provider of cold chain logistics solutions for temperature-sensitive biological materials to the life science industries. It offers liquid nitrogen dry vapor shippers with advanced logistics management platform called Cryoportal, which provides credentials rela …
  • Decas Cranberry Products, Inc.:企業の戦略・SWOT・財務情報
    Decas Cranberry Products, Inc. - Strategy, SWOT and Corporate Finance Report Summary Decas Cranberry Products, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Exxon Mobil Corp (XOM):企業の財務・戦略的SWOT分析
    Exxon Mobil Corp (XOM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • WS Atkins Plc:戦略・SWOT・企業財務分析
    WS Atkins Plc - Strategy, SWOT and Corporate Finance Report Summary WS Atkins Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • ICICI Prudential Life Insurance Company Limited:企業の戦略・SWOT・財務情報
    ICICI Prudential Life Insurance Company Limited - Strategy, SWOT and Corporate Finance Report Summary ICICI Prudential Life Insurance Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • ABX Advanced Biochemical Compounds GmbH-製薬・医療分野:企業M&A・提携分析
    Summary ABX Advanced Biochemical Compounds GmbH (ABX), a subsidiary of Otsuka Holdings Co Ltd is a biochemical compounds provider that manufactures, develops, and distributes biochemicals for nuclear medicine. The company’s products include PET and SPECT precursors and reference standards, reagents …
  • Sony Financial Holdings Inc.:企業の戦略・SWOT・財務分析
    Sony Financial Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary Sony Financial Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • ERG SpA (ERG):電力:M&Aディール及び事業提携情報
    Summary ERG S.p.A. (ERG), a subsidiary of San Quirico S.P.A., is a diversified energy company. Through its subsidiaries, it conducts power generation through renewable and thermal sources. The company carries out the distribution and marketing of petroleum products and conducts refining activities. …
  • Pt Indofood Sukses Makmur Tbk:企業の戦略・SWOT・財務分析
    Pt Indofood Sukses Makmur Tbk - Strategy, SWOT and Corporate Finance Report Summary Pt Indofood Sukses Makmur Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Vivakor Inc (VIVK):石油・ガス:M&Aディール及び事業提携情報
    Summary Vivakor Inc (Vivakor) is a technology and asset acquisition company that creates, acquires and accumulates distinct assets, intellectual properties, and various technologies. The company concentrates on precious metals extraction in the US. It also concentrates on oil extraction from shallow …
  • Tatry Mountain Resorts, AS:戦略・SWOT・企業財務分析
    Tatry Mountain Resorts, AS - Strategy, SWOT and Corporate Finance Report Summary Tatry Mountain Resorts, AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • PPG Industries Inc (PPG):企業の財務・戦略的SWOT分析
    PPG Industries Inc (PPG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Seegene Inc (096530):医療機器:M&Aディール及び事業提携情報
    Summary Seegene Inc (Seegene) is a diagnostic company that develops molecular diagnostic reagents. The company provides products such as seeplex, anyplex and magicplex among others. It develops ACP, DPO, READ, MuDT and TOCE technologies that enables to detect multiple pathogens in single reactions u …
  • JFE Holdings Inc (5411):企業の財務・戦略的SWOT分析
    JFE Holdings Inc (5411) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Touchstone Exploration Inc (TXP):石油・ガス:M&Aディール及び事業提携情報
    Summary Touchstone Exploration Inc (Touchstone), formerly Touchstone Resources Ltd is an upstream oil and gas exploration and production company that explores, produces, and develops, oil and gas properties in Trinidad and Tobago. The company holds interests, owns, and operates projects such as WD-4 …
  • Sime Darby Berhad:戦略・SWOT・企業財務分析
    Sime Darby Berhad - Strategy, SWOT and Corporate Finance Report Summary Sime Darby Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Petroleo Brasileiro S.A. (Petrobras):企業のM&A・事業提携・投資動向
    Petroleo Brasileiro S.A. (Petrobras) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Petroleo Brasileiro S.A. (Petrobras) Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆